Octopus Biosafety SA (MLOCT) Stock Statistics & Valuation Metrics

Octopus Biosafety SA has a market cap or net worth of €20.98M. The enterprise value is €3.30M.

Octopus Biosafety SA has 127,127,430 shares outstanding. The number of shares has decreased by -2.65% in one year.

Octopus Biosafety SA’s return on equity (ROE) is 1.00 and return on invested capital (ROIC) is 576.13%.

The current PE Ratio of Octopus Biosafety SA is ―. Octopus Biosafety SA’s PEG ratio is 0.07.

In the last 12 months, Octopus Biosafety SA had revenue of 52.31K and earned -659.11K in profits. Earnings per share was -0.04.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Octopus Biosafety SA pays an annual dividend of ―, resulting in a dividend yield of ―

Octopus Biosafety SA upcoming earnings date is ―, ―.

Octopus Biosafety SA as a current ratio of 0.31, with Debt / Equity ratio of ―

In the past 12 months, Octopus Biosafety SA has paid -209.06K in taxes.

Octopus Biosafety SA EV to EBITDA ratio is -21.29, with an EV/FCF ratio of 0.00.

Octopus Biosafety SA has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of -1601.06%, and net profit margin of -1260.05%.

The average price target for Octopus Biosafety SA is ―, which is 11.43% higher than the current price. The consensus rating is ―